Verrica Pharmaceuticals Balance Sheet (2020-2026) | VRCA

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Balance Sheet	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026
Assets
Current Assets
Cash & Equivalents (Quarter)	24.71M	20.44M	15.75M	50.41M	45.43M	32.47M	34.27M	59.95M	55.14M	84.31M	69.55M	48.90M	31.90M	23.00M	46.33M	29.59M	15.40M	21.10M	30.15M	20.60M
Cash & Current Investments (Quarter)	24.71M	20.44M	15.75M	50.41M	45.43M	32.47M	34.27M	59.95M	55.14M	84.31M	69.55M	48.90M	31.90M	23.00M	46.33M	29.59M	15.40M	21.10M	30.15M	20.60M
Receivables - Net (Quarter)										3.95M	4.25M	7.00M	10.03M		0.05M	5.61M	9.20M	7.05M	5.26M	7.70M
Receivables - Other (Quarter)				0.43M	0.22M	0.42M	0.10M	0.06M	0.17M	0.13M	0.17M	0.59M	0.18M	0.08M	0.03M	0.05M
Receivables (Quarter)							0.10M			4.07M	4.42M	7.59M	10.21M	0.08M	0.08M	5.65M	9.20M	7.05M	5.26M	7.70M
Raw Materials (Quarter)										0.12M	0.42M	1.15M	1.15M	1.21M	1.08M	1.05M	1.01M
Work In Process (Quarter)											0.49M	0.67M	0.68M	0.75M	0.66M	0.18M	0.52M
Finished Goods (Quarter)										0.16M	0.12M	0.68M	0.87M	0.63M	0.72M	1.23M	0.99M
Inventory (Quarter)										0.28M	1.02M	2.50M	2.70M	2.58M	2.46M	2.46M	2.52M	2.30M	2.24M	1.97M
Prepaid Assets (Quarter)	3.25M	3.66M	3.97M	3.44M	2.73M	3.52M	4.36M	3.09M	1.46M	3.07M	2.54M	2.34M	2.48M	2.56M	2.31M	1.77M	1.49M	3.59M	2.80M	2.37M
Current Assets (Quarter)	93.37M	83.16M	74.33M	65.77M	57.34M	43.40M	39.12M	63.10M	56.78M	91.72M	77.53M	61.38M	47.32M	28.19M	51.18M	39.47M	36.78M	36.27M	42.54M	34.13M
Non-Current Assets
Property, Plant & Equipment (Net) (Quarter)	3.65M	3.67M	3.89M	4.16M	4.04M	4.02M	3.89M	3.80M	3.69M	3.56M	1.05M	0.94M	0.71M	0.65M	0.59M	0.54M	0.32M	0.23M	0.21M	0.19M
Other Non-Current Assets (Quarter)	0.28M	0.26M	0.29M	0.14M	40.00M	0.22M	0.28M	0.37M	0.44M	0.53M	0.45M	0.45M	0.45M	0.54M	0.38M	0.38M	0.38M	0.38M	0.38M	0.64M
Non-Current Assets (Quarter)	5.66M	5.60M	5.80M	5.84M	6.09M	5.75M	5.61M	5.54M	5.42M	5.42M	4.07M	4.93M	4.69M	4.74M	2.96M	2.70M	2.33M	4.62M	4.59M	4.66M
Assets (Quarter)	99.03M	88.76M	80.12M	71.62M	63.44M	49.15M	44.72M	68.64M	62.20M	97.15M	81.60M	66.31M	52.01M	32.93M	54.13M	42.18M	39.11M	40.90M	47.13M	38.79M
Liabilities
Current Liabilities
Accounts Payables (Quarter)	0.78M	0.90M	0.84M	0.53M	0.71M	0.14M	0.51M	0.57M	2.06M	1.93M	2.46M	2.53M	1.15M	0.97M	1.90M	1.44M	2.32M	1.58M	2.07M	2.19M
Notes Payables (Quarter)	41.01M	41.35M	41.69M	42.00M	42.29M
Payables (Quarter)	41.79M	42.25M	42.54M	42.53M	43.01M	0.14M	0.51M	0.57M	2.06M	1.93M	2.46M	2.53M	1.15M	0.97M	1.90M	1.44M	2.32M	1.58M	2.07M	2.19M
Accumulated Expenses (Quarter)	3.25M	3.88M	0.25M	2.01M	2.41M	2.65M	2.65M	1.77M	1.12M	2.04M	13.86M	1.39M	2.34M	18.90M	13.51M	14.48M	13.10M	12.60M	12.84M	12.25M
Other Accumulated Expenses (Quarter)										0.28M	0.24M	0.32M	0.30M	0.43M	0.10M	0.17M	0.37M
Short term Debt (Quarter)	41.01M	41.35M	41.69M	42.00M	42.29M										12.94M	12.82M	12.67M	12.46M
Current Leases (Quarter)	0.01M	0.01M	0.24M	0.25M	0.28M		0.30M	0.30M	0.31M	0.03M	0.38M	0.68M	0.33M	0.85M	0.35M	0.32M	0.33M	0.37M	0.34M	0.40M
Current Deferred Revenue (Quarter)																	0.48M	1.56M	0.78M	1.03M
Total Current Liabilities (Quarter)	45.28M	46.37M	46.05M	44.80M	45.71M	3.08M	3.46M	2.64M	5.73M	11.37M	17.02M	19.36M	20.05M	21.03M	29.01M	29.40M	29.22M	28.91M	16.44M	16.22M
Non-Current Liabilities
Capital Leases (Quarter)	0.02M	0.02M	0.02M	0.01M	0.01M					0.08M	1.03M	1.76M	1.76M	1.98M	0.77M	0.66M	0.58M	0.63M	0.64M	0.55M
Operating Leases (Quarter)	1.57M	1.51M	1.45M	1.38M	1.38M	1.30M	1.23M	1.15M	1.07M	0.99M	0.91M	0.82M	0.74M	0.67M	0.58M	0.50M	0.42M	0.67M	0.24M	0.50M
Other Non-Current Liabilities (Quarter)									0.01M	0.01M					2.65M	2.39M	1.80M	1.76M
Total Non-Current Liabilities (Quarter)									6.79M	54.84M	61.83M				61.35M	58.36M	54.80M	56.17M	22.39M
Total Liabilities (Quarter)	46.87M	47.90M	47.52M	46.20M	47.10M	4.38M	4.69M	3.79M	6.80M	54.84M	61.83M	64.80M	65.31M	66.98M	63.99M	60.75M	56.59M	57.94M	22.39M	22.73M
Shareholder's Equity
Total Debt (Quarter)	41.01M	41.35M	41.69M	42.00M	42.29M										12.94M	12.82M	12.67M	12.46M
Common Equity (Quarter)	52.16M	40.85M	32.60M	25.42M	16.33M	44.77M	40.03M	64.85M	55.40M	42.30M	19.76M	1.51M	-13.30M	-34.05M	-9.86M	-18.58M	-17.48M	-17.04M	24.74M	16.05M
Shareholder's Equity (Quarter)	52.16M	40.85M	32.60M	25.42M	16.33M	44.77M	40.03M	64.85M	55.40M	42.30M	19.76M	1.51M	-13.30M	-34.05M	-9.86M	-18.58M	-17.48M	-17.04M	24.74M	16.05M
Liabilities and Shareholders Equity (Quarter)	99.03M	88.76M	80.12M	71.62M	63.44M	49.15M	44.72M	68.64M	62.20M	97.15M	81.60M	66.31M	52.01M	32.93M	54.13M	42.18M	39.11M	40.90M	47.13M	38.79M
Retained Earnings (Quarter)	-0.00M	-129.43M	-0.03M	-147.40M	-0.06M	-157.50M	-163.45M	-170.04M	-181.00M	-205.83M	-230.45M	-250.80M	-267.96M	-290.82M	-307.03M	-316.77M	-316.56M	-316.84M	-324.91M	-334.60M
Treasury Shares (Quarter)	0.47M	0.11M	0.42M	0.11M	0.42M	0.42M	0.42M	0.11M	0.11M	0.11M	0.01M	0.01M	0.01M	0.01M	0.01M	0.01M	0.01M	0.03M	0.01M	0.01M

Research Tools

Verrica Pharmaceuticals Balance Sheet (2020-2026) | VRCA

Create an account

Sign In

Reset Password